#DOAC

Enrico Ferro, MD

Would you care for a pragmatic understanding of cost-effectiveness for new #cardiovascular drugs? In our new @Heart_BMJ article, we use 3 case studies to clarify key concepts like cost-effectiveness &

Nathan Connell, MD, MPH

Great to see many ID and EM colleagues verified by @Twitter! OK #hemetwitter let’s get @TwitterSupport to grant that @verified blue checkmark to thrombosis/hemostasis physicians confronting #COVID19! Who do we

Diego Araiza, MD

2020 ESC Guidelines on NSTEACS: - 10 key concepts to remember and messages that will change our practice - #ESCCongress #ESC_Acute #Acutecvd 1/ Diagnosis of NSTEACS is based on -

Vinay Prasad MD MPH

Ok, here is a little #Tweetorial about #COVID19 and whether, outside of a controlled trial, we should be using different:1. rules for anti-coagulation/ lytics2. ventilatory settings in ARDS3. anti-virals/ anti-inflammatories

Let's HIT the topic Heparin-induced Thrombocytopenia (HIT)!This #tweetorial is a deep dive into Episode 43 of Run the List (RTL) on Thrombocytopenia: https://bit.ly/32feVfQ Thanks @LeelaChock for covering this week’s topic!

Gretchen Winter, MD 🌼

At the request of several people, here is a thread on acute liver failure and decompensated cirrhosis in the ICU. Disclaimer: This is a broad overview of some key issues,